✦ LIBER ✦

Pharmacokinetics of repeated i.v. bolus administration of high doses of r-met-Hu interleukin-2 in advanced cancer patients

✍ Scribed by J. P. Sculier; J. J. Body; N. Donnadieu; S. Nejai; F. Glibert; N. Raymakers; M. Paesmans

Publisher: Springer
Year: 1990
Tongue: English
Weight: 370 KB
Volume: 26
Category: Article
ISSN: 0344-5704
DOI: 10.1007/bf02897293

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Haemodynamic effects induced by intraven

Haemodynamic effects induced by intravenous administration of high doses of r-Met Hu IL-2 [ala-125] in patients with advanced cancer

✍ D. Diana; J. P. Sculier 📂 Article 📅 1990 🏛 Springer 🌐 English ⚖ 337 KB

Trends in the safety of high dose bolus

Trends in the safety of high dose bolus interleukin-2 administration in patients with metastatic cancer

✍ Udai S. Kammula; Donald E. White; Steven A. Rosenberg 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB 👁 2 views

## BACKGROUND. Administration of recombinant high dose interleukin-2 (IL-2) can mediate tumor regression in patients with metastatic melanoma and renal carcinoma. Significant trends in the safety of high dose IL-2 administration at a single institution over a 12-year study period were reviewed. #

High-dose epirubicin and r-met-hu G-CSF

High-dose epirubicin and r-met-hu G-CSF (Filgrastim) in the treatment of patients with advanced breast cancer: A hellenic cooperative oncology group study

✍ Fountzilas, George ;Skarlos, Demosthenis ;Katsohis, Constantine ;Pavlidis, Nicho 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 525 KB

Adjuvant adoptive immunotherapy with tum

Adjuvant adoptive immunotherapy with tumour-infiltrating lymphocytes and modulated doses of interleukin-2 in 22 patients with melanoma, colorectal and renal cancer, after radical metastasectomy, and in 12 advanced patients

✍ R. Ridolfi; Emanuela Flamini; Angela Riccobon; F. De Paola; Roberta Maltoni; A. 📂 Article 📅 1998 🏛 Springer-Verlag 🌐 English ⚖ 184 KB